Opioids Settlement Accounting: Choosing the Right Treatment - American Institute of CPAs
The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
State and local governments stand to receive more than $54 billion over 18 years from legal settlements with the manufacturers, distributors, and retailers of prescription opioids. The complexity of the settlement provisions and differences in how states are handling the distribution of proceeds to localities have resulted in there being no single answer to the question, "How should my government account for and report the settlement money?" This session lays out the steps that governments and their auditors should take and the questions they should ask in order to determine the appropriate accounting and financial reporting standards to follow.
Learning Objectives:
Identify the key factors that determine the appropriate accounting
Distinguish between the settlement provisions that are most relevant to the accounting standards
Identify the applicability of exchange versus nonexchange transactions and program versus general revenue
Speaker(s):
Dean
M. Mead,
CGFM,
Partner, Government & Public Sector,
Carr, Riggs & Ingram CPAs and Advisors
You must be logged in and own this session in order to
post comments.